- U.S.-based biotechnology company Anew Medical (NASDAQ:WENA) appointed Jeffrey LeBlanc as the company’s CFO, replacing the interim CFO, Edward Cong Wang who was the former CFO of Redwoods Acquisition Corp into which ANEW merged.
- Earlier in his career, Jeff served in investment roles at Greenlight Capital and GE Capital, after having started his career at McKinsey and Co.
